Rainer Böhnke
5 Marks
Individual
First Filed:Dec 22, 2020Latest Filed:Sep 3, 2021Address:Imbrosweg 23, Berlin, 12109, DE
Portfolio Overview
Top Classes
Class 5
PharmaceuticalsClass 10
Medical ApparatusTTAB Proceedings
Proceedings
0As Plaintiff
0(0%)As Defendant
0(0%)Extensions of Time
1Top Firms
Loading...
Trademark Portfolio
5 results
(current & previous marks)
Refine by Mark/Description🔽
Filed
Registered
Last Activity
Filters
Ownership
5
0
Status
3
0
0
2
0
Mark Type
2
1
0
2
0
TTAB
0
0
5
4
1

Description: Medicines for human purposes for the treatment or prophylaxis of the nervous system, for treatment or prophylaxis of the endocrine system, for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable disinfectant , injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment of or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and proteoglycan-associated disease or disorder; pharmaceuticals, namely, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia, of heterozygous familial hypercholesterolemia, of diabetic foot syndrome, of arterial hypertension or cardiac insufficiency; pharmaceuticals, namely, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, of vascular dementia, of Parkinson's disease, of multiple sclerosis, of amyotrophic lateral sclerosis, of cerebral insult, of brain trauma, of cerebral inflammations, and of autoimmune encephalitis; pharmaceuticals, namely, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, of enthesiopathy, of insertion tendinosis, of insertion tendinopathy, of tendonitis, of periarthritis, of periathrosis, of arthrosis, of osteoarthrosis, of fibrosis, of renal fibrosis, of liver fibrosis, of cardiac fibrosis, of cardiac valve fibrosis, of pulmonary fibrosis, of pulmonary cirrhosis, of pulmonary sclerosis, of cerebral insult, of cerebral stroke, of apoplectic insult, of apoplexia cerebri, of ictus apoplecticus, of cerebral infarction, of brain scars, of gliosis,of contracture, of fibrotendinous contracture, of fibrous contracture, of joint contracture, of tendon contracture, of Dupuytren's contracture, of Dupuytren's disease, of Dupuytren's contracture, of glaucoma, of eye pressure elevation, of intraocular pressure elevation, of primary chronic glaucoma, of Multiple sclerosis, of disseminated demyelinating encephalomyelitis, of encephalomyelitis disseminata, of encephalitis disseminata, of cerebral polysclerosis, of amyotrophic lateral sclerosis, of myatrophic lateral sclerosis, of motoneuron disease, of Lou Gehrig's syndrome, of postcovid syndrome, of longcovid syndrome; cardiovascular agents for medical purposes; pharmaceutical preparations for treating hypertension; cardiovascular drugs used in angina pectoris, namely, drug delivery agents in the form of tablets, capsules, sprays, injections that provide controlled release of active ingredients for use in treating angina pectoris; cardiovascular drugs, namely, drug delivery agents in the form of tablets, capsules, sprays, injections, that provide controlled release of active ingredients for use in treating congestive heart failure; cardiovascular drugs, namely, drug delivery agents in the form of tablets, capsules, sprays, injections that provide controlled release of active ingredients for use in myocardial infarction; pharmaceutical preparations for the treatment of heart rhythm disorders; antiseptics; anti-inflammatory preparations; pharmaceuticals for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for the treatment of parkinson's disease; pharmaceutical preparations for the treatment of kidney diseases; anti-cancer drugs, namely, pharmaceutical products for the prevention and treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for use in ophthalmology; amino acid preparations for medical purposes; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for activating cellular function; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of musculo-skeletal disorders; ferments for medical or veterinary use; eye bandages for medical use; living cells for medical use; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for the treatment of hyperlipidemia; medicines for dental purposes; diagnostic preparations for medical or veterinary purposes; diagnostic agents for medical pharmaceutical use; biological indicators for medical diagnosis; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; clinical diagnostic reagents for medical use; in vitro diagnostic preparations for medical use; reagents for in-vitro laboratory use for medical purposes; immunoassay reagents for medical use; medical diagnostic test strips for detection of h-FABP being Heart-type Fatty Acid-Binding protein in the diagnosis of myocardial infarct, for detection of cTnI being Troponin I in the diagnosis of myocardial infarct, for detection of SARS-CoV-2 antigen in the diagnosis of Corona disease, for detection of proinsulin for diagnosis of humans with abnormal insulin secretion, for the detection of YKL-40 being CHI3L1 protein for diagnosis and treatment of liver fibrosis; test strips for measuring blood glucose levels; impregnated medicated swabs; wadding for medical purposes; swabs for medical use; cellulose wadding for medical purposes; tampons for medical purposes; reagent paper for medical or veterinary purposes; impregnated pre-moistened medicated wipes; mouthwashes for medical purposes | Medical diagnostic apparatus for testing for viruses; medical apparatus for analysing bacteria in biological samples; medical instruments for infectious disease testing; medical diagnostic testing instruments for use in immunoassay procedure; genetic testing apparatus for medical purposes; medical devices for obtaining body fluid samples, namely, meters for body fluids; medical test kits for diabetes monitoring for home use; medical apparatus for diagnosing suspected heart attacks; apparatus for DNA and RNA testing for medical purposes; chromatographic instruments for medical use for detection of h-FABP being Heart-type Fatty Acid-Binding protein in the diagnosis of myocardial infarct, for detection of cTnI being Troponin I in the diagnosis of myocardial infarct, for detection of SARS-CoV-2 antigen in the diagnosis of Corona disease, for detection of proinsulin for diagnosis of humans with abnormal insulin secretion, for the detection of YKL-40 being CHI3L1 protein for diagnosis and treatment of liver fibrosis; diagnostic measuring apparatus for medical use for detection of h-FABP being Heart-type Fatty Acid-Binding protein in the diagnosis of myocardial infarct, for detection of cTnI being Troponin I in the diagnosis of myocardial infarct, for detection of SARS-CoV-2 antigen in the diagnosis of Corona disease, for detection of proinsulin for diagnosis of humans with abnormal insulin secretion, for the detection of YKL-40 being CHI3L1 protein for diagnosis and treatment of liver fibrosis; diagnostic apparatus for medical purposes, namely, ultrasound diagnostic apparatus, diagnostic apparatus for detection of cancer, diagnostic apparatus for detection of myocardial infarct, diagnostic apparatus for detection of cardiac rhythm disorder, diagnostic apparatus for detection of hypertension, diagnostic apparatus for detection of liver fibrosis, diagnostic apparatus for detection of hypercholesterolemia, diagnostic apparatus for detection of heterozygous familial hypercholesterolemia, diagnostic apparatus for detection of diabetic foot syndrome, diagnostic apparatus for detection of Alzheimer's disease, diagnostic apparatus for detection of vascular dementia, diagnostic apparatus for detection of Parkinson's disease, diagnostic apparatus for detection of multiple sclerosis, diagnostic apparatus for detection of amyotrophic lateral sclerosis, diagnostic apparatus for detection of cerebral insult, diagnostic apparatus for detection of brain trauma, diagnostic apparatus for detection of cerebral inflammations, and diagnostic apparatus for detection of autoimmune encephalitis; testing apparatus for medical purposes for testing blood sugar levels, for testing cancer cells, for testing DNA; protective face masks for medical use for anti bacterial protection; blood collection tubes for medical use; medical diagnostic saliva vials; temperature indicator labels for medical purposes; temperature measuring instruments for medical use in the nature of clinical thermometers; medical devices, namely, receptacles for applying medicines; patient monitoring instruments, namely, heart rate monitoring apparatus; containers especially made for medical waste; medical diagnostic testing instruments for use in immunoassay procedure; medical device, namely, immunoadsorption columns for therapeutic use; specimen cup holders; gamma cameras for medical purposes; light sources for medical use, namely, light emitting diode apparatus for lighting, incorporated into medical instruments; lancets; measuring devices for medical use in the nature of devices for measuring wounds, devices for measuring blood sugar for medical purposes; blood lancets; pipetting instruments in the nature of dropping pipettes for medical use; blood glucose testing apparatus; medical device, namely, immunoadsorption columns for diagnostic use; spittoons for medical purposes | Pharmaceutical research and development; quality control for others; pharmaceutical product evaluation; consultancy pertaining to pharmacology; laboratory research services relating to pharmaceuticals | Medical services; medical testing services relating to the diagnosis and treatment of disease; medical analysis for the diagnosis and treatment of persons; medical laboratory services for the analysis of samples taken from patients; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of animals provided by medical laboratory; medical treatment services of treating myocardial infarct, hypertension, liver fibrosis, hypercholesterolemia , heterozygous familial hypercholesterolemia, diabetic foot syndrome, Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis , cerebral insult, brain trauma, cerebral inflammations, and autoimmune encephalitis; medical testing for diagnostic or treatment purposes; medical services for the treatment of skin cancer; health care services for treating alzheimer's disease; medical analysis of human serum for medical treatment; providing information relating to the treatment of cardiovascular and cerebrovascular diseases via the internet; medical services relating to the removal, treatment and processing of human blood; medical services relating to the removal, treatment and processing of human cells; medical services in the nature of pharmacologicaltherapy services for treating myocardial infarct, hypertension, liver fibrosis, hypercholesterolemia , heterozygous familial hypercholesterolemia, diabetic foot syndrome, Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis,cerebral insult, brain trauma, cerebral inflammations, and autoimmune encephalitis



Description: Reagents for medical use; diagnostic chemical reagents for medical use; clinical medical reagents; clinical diagnostic reagents for medical purposes; enzymes for medical purposes with all of the foregoing for use in testing and diagnosing Sars-Cov-2 exposure; medical preparations and chemicals for pharmaceutical use, namely, for use in the treatment and disagnosis of SARS,COV-2 or Covid-19; pharmaceutical preparations in strip form for the treatment of Covid-19; pharmaceutical preparations for the prevention of disorders of the endocrine system that may be affected by Covid-19; chemical preparations for testing blood for medical purposes to determine Sars-Cov-2 or Covid-19 exposure; chemical preparations for medical purposes, namely, for the treatment of Covid-19; chemico-pharmaceutical preparations for the treatment of Covid-19; pharmaceutical preparations for the prevention of diseases of the metabolic system, in particular, Sars-Cov-2; in-vitro reagents for medical diagnostic purposes to determine exposure to Sars-Cov-2; chemical preparations for pharmaceutical purposes, namely, for treatment of Covid-19; medical diagnostic test strips for testing for Covid-19 viral infection; diagnostic agents for medical use and diagnostic reagents for medical use in testing for Sars-Cov-2 exposure; medicated mouth spray for treating Covid-19 viral infections; pharmaceutical preparations for the prevention of disorders of the metabolic system related to Sars-Cov-2 exposure; pharmaceutical preparations for the treatment of Covid-19 viral infections; chemical preparations for use in DNA analysis for medical purposes related to diagnosing and treating Sars-Cov-2; biological reagents for medical diagnostic use for medical purposes related to diagnosing and treating Sars-Cov-2; diagnostic chemical reagents for medical use related to diagnosing and treating Sars-Cov-2

Description: In-vitro reagents for diagnostic veterinary use; in-vitro reagents for diagnostic medical use; in-vitro diagnostic preparations for medical use; immunoassay reagents for medical use; insulin; genetic identity tests comprised of reagents for medical purposes; chemical test reagents for veterinary use; medical diagnostic test strips; medical diagnostic reagents and assays for testing of body fluids; test strips for measuring blood glucose levels; reagents for use in medical genetic testing; reagents for use in diagnostic tests for medical purposes; cotton swabs for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use in veterinary genetic testing; chemical test reagents for medical use; reagents for use with analyzers for medical use; reagents for use with analyzers for veterinary purposes; reactants for veterinary diagnosis; swabs for medical use; reagents for medical use; biological indicators for medical diagnosis; indicators for medical diagnosis, namely, biological indicators for monitoring sterilization processes for medical purposes; diagnostic chemical reagents for medical use; reactants for medical diagnosis; diagnostic preparations for medical or veterinary purposes; cotton wool in the form of sticks for medical use; chemical reagents for veterinary use; cellulose wadding for medical purposes; diagnostic substances for medical use; reagents for use in analysis for veterinary purposes; enzymes for medical purposes; reagents for analytical purposes for veterinary purposes; tampons for medical purposes; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic testing materials, namely, chemical preparations, chemical reagents, test strips, biological indicators for medical use; enzyme preparations for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for medical purposes, namely, chemical preparations for medical and veterinary diagnostic purposes; chemical preparations for medical purposes for the treatment of treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; cellulose wool for medical use; reagents for analytical purposes for medical purposes; chemical reagents for medical use; enzyme preparations for veterinary purposes; reagent paper for medical or veterinary purposes; impregnated medicated wipes; medicinal preparations and substances, namely, for the treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; reagents for microbiological analysis for veterinary purposes; impregnated medicated swabs; diagnostic reagents for medical use; enzymes for veterinary purposes; reagents for microbiological analysis for medical purposes; reagent paper for medical purposes; reagent paper for veterinary purposes; capillary stabilizing agents for medical purposes; diagnostic agents for medical use; wadding for medical purposes; dental preparations for disclosing plaque | Insulin syringes sold empty; genetic testing apparatus for medical purposes; diagnostic testing instruments for use in immunoassay procedure for medical use; testing apparatus for medical purposes, namely, genetic testing apparatus for medical purposes, DNA and RNA testing apparatus for medical purposes, medical diagnostic apparatus for testing for blood analysis, plasma analysis, serum analysis, blood component analysis, feces analysis, urine analysis, tissue analysis, tissue fliud analysis, body secretion analysis; membrane test plates for use in medical diagnostics; medical test kits for diabetes monitoring for home use; test probes for medical use; apparatus for carrying-out diagnostic tests for medical purposes, namely, ultrasound diagnostic apparatus, nuclear medical diagnostic imaging apparatus, medical apparatus for diagnostic radiopharmaceutical use, organoleptic diagnostic testing apparatus; diagnostic testing instruments for use in immunoassay procedure for medical purposes; testing apparatus for medical purposes, namely, for immunochemical tesing, diagnostic apparatus for testing for viruses or bacteria, genetic testing apparatus, apparatus for DAN and RNA testing for medical purposes; medical apparatus and instruments, namely, medical radiation apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, electromagnetic drug delivery apparatus for medical use, medical instruments for cutting tissues, medical instruments for examing women's reproductive organs, medical instruments for use in general surgery, medical instruments for use in performing biopsies; medical apparatus for testing the level of glucose in the blood; chromatographic apparatus for medical purposes; medical diagnostic apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; measuring devices for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices measuring tumors; chromatographic devices for medical purposes; measuring instruments adapted for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices measuring tumors; tongue depressors for medical purposes; apparatus for analysing substances, namely, body fluids, blood, body tissues, bacterial cultures, mucous for medical use; medical therapy instruments, namely, implantable radiation therapy devices consisting of radioactive seeds, medical devices for moxibustion therapy, a device for improving cardiac performance through aortic flow therapy; blood collection tubes for medical use; chromatographic columns for medical use; medical diagnostic saliva vials; blood group analyzers for medical use; fibrescopes for medical use; chromatogram analyzers for medical use; medical analytical apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; automated analyzers for foreign matter contained in body fluids for medical use; chromatographic instruments for medical use; medical apparatus for diagnosing suspected heart attacks; diagnostic measuring apparatus for medical use, namely, blood pressure, blood flow, devices for measuring wounds, devices for measuring body position and leg movements during sleep, audiometers for measuring hearing loss, apparatus for measuring skin hydration, devices meauring tumors; diagnostic apparatus for medical purposes, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; apparatus for DNA and RNA testing for medical purposes; electronic apparatus for medical purposes, namely, electronic medical appliances for wound healing, electronic temperature monitors, electronic muscle stimulators, EKG machines, medical apparatus for monitoring vital signs, blood property and respiratory events; chromatography plates for medical use; chromatographic instruments for medical purposes; body composition analyzers for medical purposes